ウイルス不活化の世界市場：製品（キット、試薬、装置、サービス）、用途、方法、エンドユーザー、地域別分析...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions

3 Executive Summary (Page No. – 23)

4 Premium Insights (Page No. – 28)
4.1 Global Viral Inactivation Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 32)
5.1 Introduction
5.1.1 Market Segmentation
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
5.2.1.2 Increasing Number of New Drug Launches
5.2.1.3 Strong R&D Investments in the Life Sciences Industry
5.2.1.4 Increasing Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.5 High Incidence and Large Economic Burden of Chronic Diseases
5.2.2 Restraint
5.2.2.1 High Degree of Consolidation to Act as A Major Barrier for New Entrants
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.3.2 Developing Countries Present Significant Growth Opportunities for the Market
5.2.4 Challenge
5.2.4.1 Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Viral Inactivation Products

6 Viral Inactivation Market, By Method (Page No. – 41)
6.1 Introduction
6.2 Solvent Detergent Method
6.3 Pasteurization
6.4 Other Methods

7 Viral Inactivation Market, By Product (Page No. – 47)
7.1 Introduction
7.2 Kits and Reagents
7.3 Services
7.4 Viral Inactivation Systems and Accessories

8 Viral Inactivation Market, By Application (Page No. – 54)
8.1 Introduction
8.2 Vaccines and Therapeutics
8.3 Blood and Blood Products
8.4 Cellular and Gene Therapy Products
8.5 Tissues and Tissue Products
8.6 Stem Cell Products

9 Viral Inactivation Market, By End User (Page No. – 64)
9.1 Introduction
9.2 Pharmaceutical and Biotechnology Companies
9.3 Contract Research Organizations
9.4 Academic Research Institutes
9.5 Other End Users

10 Viral Inactivation Market, By Geography (Page No. – 73)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia
10.5 Rest of the World

11 Competitive Landscape (Page No. – 111)
11.1 Overview
11.2 Strategic Overview
11.3 Leading Players in the Viral Inactivation Market
11.4 Competitive Situation and Trends
11.4.1 Expansions
11.4.2 Acquisitions
11.4.3 Agreements, Collaborations, and Partnerships
11.4.4 Services Launches

12 Company Profiles (Page No. – 119)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm View)*
12.1 Introduction
12.2 Danaher Corporation
12.3 Merck KGAA
12.4 Parker Hannifin Corporation
12.5 Sartorius AG
12.6 SGS SA
12.7 Charles River Laboratories International, Inc.
12.8 Clean Cells Inc.
12.9 Rad Source Technologies, Inc.
12.10 Texcell, Inc.
12.11 Viral Inactivated Plasma Systems SA
12.12 Wuxi Pharmatech (Cayman) Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 145)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports